BIOCORP: 2022 Financial Calendar
05 Januar 2022 - 6:00PM
Business Wire
Regulatory News:
BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA‐PME),
a French company specialized in the design, development, and
manufacturing of innovative medical devices, presents its financial
reporting schedule for 2022(1).
Annonce
Date*
2021 full-year results
Thursday, April 7th, 2022
Before the market opening
Annual shareholders meeting
Tuesday, May 17th, 2022
2022 first-half results
Thursday, September 29th,
2022
Before the market opening
(1) This schedule is indicative and subject to change.
ABOUT BIOCORP
Recognized for its expertise in the development and manufacture
of medical devices and delivery systems, BIOCORP has today acquired
a leading position in the connected medical device market thanks to
Mallya. This smart sensor for insulin injection pens allows
reliable monitoring of injected doses and thus offers better
compliance in the treatment of patients with diabetes. Available
for sale from 2020, Mallya spearheads BIOCORP's product portfolio
of innovative connected solutions. The company has 70 employees.
BIOCORP is listed on Euronext since July 2015 (FR0012788065 –
ALCOR).
For more information, please visit www.biocorpsys.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220105005556/en/
BIOCORP Jacques Gardette Chairman of the Board
investisseurs@biocorp.fr
Éric Dessertenne Chief Executive Officer
Sylvaine Dessard Marketing & Communication Director
rp@biocorp.fr + 33 (0)6 88 69 72 85
CONTACTS ULYSSE COMMUNICATION Bruno ARABIAN
barabian@ulysse-communication.com +33 (0)6 87 88 46 26
Nicolas DANIELS ndaniels@ulysse-communication.com +33 (0)6 63 66
59 22
Biocorp (EU:ALCOR)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Biocorp (EU:ALCOR)
Historical Stock Chart
Von Apr 2023 bis Apr 2024